Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2112.4520.35 (+0.97 %)

PREV CLOSE ( ) 2092.10

OPEN PRICE ( ) 2122.25

BID PRICE (QTY) 2109.70 (35)

OFFER PRICE (QTY) 2113.15 (7)

VOLUME 4622

TODAY'S LOW / HIGH ( )2095.75 2136.85

52 WK LOW / HIGH ( )1240.75 2488.65

NSE2131.7539.2 (+1.87 %)

PREV CLOSE( ) 2092.55

OPEN PRICE ( ) 2120.05

BID PRICE (QTY) 2131.75 (15)

OFFER PRICE (QTY) 2133.10 (1)

VOLUME 90504

TODAY'S LOW / HIGH( ) 2093.05 2137.90

52 WK LOW / HIGH ( )1242 2490

Chairman	Ramesh Juneja
Managing Director	Rajeev Juneja
Company Secretary	Pradeep Chugh
Non Executive Independent Director	Surendra Lunia T P Ostwal Vijaya Sampath Bharat Anand Vivek Kalra
Whole Time Director	Sheetal Arora Satish Kumar Sharma

Incorporation Year : 03-07 1991

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111 New Delhi,
Delhi-110020 .

Phone : 011-46846700

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE